Johnson & Johnson (JNJ) Stock Could Soon Reward Patient Investors

Johnson & Johnson (NYSE: JNJ) is 0.01% higher on its value in year-to-date trading and has touched a low of $144.95 and a high of $175.97 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The JNJ stock was last observed hovering at around $156.40 in the last trading session, with the day’s gains setting it 0.36%.

Currently trading at $156.76, the stock is -1.65% and -0.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.53 million and changing 0.23% at the moment leaves the stock -1.81% off its SMA200. JNJ registered -4.19% loss for a year compared to 6-month loss of -8.95%. The firm has a 50-day simple moving average (SMA 50) of $4.51 and a 200-day simple moving average (SMA200) of $17.44.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -3.16% gain in the last 1 month and extending the period to 3 months gives it a 4.26%, and is 0.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.27% over the week and 1.15% over the month.

Johnson & Johnson (JNJ) has around Feb 16 2024 employees, a market worth around $377.37B and $93.02B in sales. Current P/E ratio is 28.11 and Fwd P/E is 14.25. Profit margin for the company is 15.23%. Distance from 52-week low is 8.15% and -10.92% from its 52-week high. The company has generated returns on investments over the last 12 months (14.57%).

Johnson & Johnson quarterly earnings per share for the current quarter are estimated at $2.63 with sales reaching $21.4B over the same period.The EPS is expected to grow by 7.49% this year, but quarterly earnings will post 3.80% year-over-year. Quarterly sales are estimated to shrink -13.50% in year-over-year returns.

Johnson & Johnson (JNJ) Top Institutional Holders

4,664 institutions hold shares in Johnson & Johnson (JNJ), with institutional investors hold 71.02% of the company’s shares. The shares outstanding are 2.61B, and float is at 2.40B with Short Float at 0.51%. Institutions hold 70.96% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 247.48 million shares valued at $40.96 billion. The investor’s holdings represent 9.52% of the JNJ Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 199.34 million shares valued at $33.0 billion to account for 7.67% of the shares outstanding. The other top investors are State Street Corporation which holds 141.83 million shares representing 5.46% and valued at over $23.48 billion, while Geode Capital Management, LLC holds 1.91% of the shares totaling 49.7 million with a market value of $8.23 billion.

Johnson & Johnson (JNJ) Insider Activity

A total of 5 insider transactions have happened at Johnson & Johnson (JNJ) in the last six months, with sales accounting for 5 and purchases happening 0 times. The most recent transaction is an insider sale by Hait William. SEC filings show that Hait William sold 14,698 shares of the company’s common stock on Jul 26 at a price of $172.00 per share for a total of $2.53 million. Following the sale, the insider now owns 87747.0 shares.

Johnson & Johnson disclosed in a document filed with the SEC on Jul 25 that Fasolo Peter (Exec VP, Chief HR Officer) sold a total of 20,000 shares of the company’s common stock. The trade occurred on Jul 25 and was made at $170.32 per share for $3.41 million. Following the transaction, the insider now directly holds 0.1 million shares of the JNJ stock.

Still, SEC filings show that on Jun 12, Wengel Kathryn E (EVP, Chief TO and Risk Officer) disposed off 12,465 shares at an average price of $160.00 for $1.99 million. The insider now directly holds 65,934 shares of Johnson & Johnson (JNJ).

Johnson & Johnson (JNJ): Who are the competitors?

The company’s main competitors (and peers) include Procter & Gamble Co. (PG) that is trading 12.39% up over the past 12 months. Rogers Corp. (ROG) that is -19.18% lower over the same period.